| Literature DB >> 35618573 |
Stefan R Torborg1, Zhuxuan Li2, Jason E Chan3, Tuomas Tammela4.
Abstract
Cancer cells are plastic - they can assume a wide range of distinct phenotypes. Plasticity is integral to cancer initiation and progression, as well as to the emergence and maintenance of intratumoral heterogeneity. Furthermore, plastic cells can rapidly adapt to and evade therapy, which poses a challenge for effective cancer treatment. As such, targeting plasticity in cancer holds tremendous promise. Yet, the principles governing plasticity in cancer cells remain poorly understood. Here, we provide an overview of the fundamental molecular and cellular mechanisms that underlie plasticity in cancer and in other biological contexts, including development and regeneration. We propose a key role for high-plasticity cell states (HPCSs) as crucial nodes for cell state transitions and enablers of intra-tumoral heterogeneity.Entities:
Keywords: cancer therapy; cell state transition; differentiation; intratumoral heterogeneity; plasticity; tumor evolution
Mesh:
Substances:
Year: 2022 PMID: 35618573 PMCID: PMC9388572 DOI: 10.1016/j.trecan.2022.04.007
Source DB: PubMed Journal: Trends Cancer ISSN: 2405-8025